VarGroup Info
Variable Group Information
Ely | Release 1
Medication (All variables related to Medication) 31
Name
Label
Description
Unit
DataType
on treatment aceinhibitor at P3
Phase 3: on treatment ace inhibitor at Phase 3, 0 = , 1 =
Categorical
on treatment alfablocker at P3
Phase 3: on treatment alfablocker at phase 3, 0 = , 1 =
Categorical
on treatment antiBP at P3
Phase 3: on treatment antiBP at Phase 3, 0 = , 1 =
Categorical
on treatment antilipid at P3
Phase 3: on treatment antilipid at Phase 3, 0 = 1 =
Categorical
on treatment antiplatelet at P3
Phase 3: on treatment antiplatelet at phase 3, 0 = 1, =
Categorical
on treatment at2blocker at P3
Phase 3: on treatment at2blocker at Phase 3, 0 = , 1 =
Categorical
on treatment betablocker at P3
Phase 3: on treatment betablocker at Phase 3. 0 = , 1 =
Categorical
BL on treatment with ACEI
Phase 1: treated with angiotensin converting enzyme (ACE) inhibitor? 0 = no; 1 = yes;
Categorical
BL on treatment for angina
Phase 1: baseline on treatment for angina 0 = no; 1 = yes;
Categorical
BL on treatment with antiepileptic
Phase 1: baseline on treatment with antiepileptic 0 = no; 1 = yes;
Categorical
BL on asthma treatment
Phase 1: baseline on asthma treatment 0 = no; 1 = yes;
Categorical
BL on treatment with betablockers
Phase 1: baseline on treatment with betablockers 0 = no; 1 = yes;
Categorical
BL BP modifying therapy
Phase 1: baseline blood pressure modifying therapy 0 = no; 1 = yes;
Categorical
BL on treatment with calcium antagonist
Phase 1: baseline on treatment with calcium antagonist 0 = no; 1 = yes;
Categorical
BL on treatment with diuretic
Phase 1: baseline on treatment with diuretic 0 = no; 1 = yes;
Categorical
BL on treatment for dyslipidaemia
Phase 1: baseline on treatment for dyslipidaemia 0 = no; 1 = yes;
Categorical
BL on treatment for gout
Phase 1: baseline on treatment for gout 0 = no; 1 = yes;
Categorical
BL on treatment with H2 antagonist
Phase 1: baseline on treatment with H2 antagonist 0 = no; 1 = yes;
Integer
BL on treatment for hypertension
Phase 1: baseline on treatment for hypertension. 0 = No treatment; 1 = on treatment for hypertension;
Integer
BL on treatment with oral steroids
Phase 1: baseline on treatment with oral steroids 0 = no; 1 = yes;
Categorical
BL on thyroid replacement treatment
Phase 1: baseline on thyroid replacement treatment 0 = no; 1 = yes;
Categorical
BL on treatment with tricyclics
Phase 1: baseline on treatment with tricyclics 0 = no; 1 = yes;
Categorical
on treatment cachblocker at P3
Phase 3: on treatment cachblocker at Phase 3. 0 = , 1 =
Categorical
treated with ACEI at FUP
Phase 2: On treatment Ace Inhibitor at follow up, 0 =; 1 =
Categorical
P2 treated for hypertension
Phase 2: Treated for hypertension at follow-up
Categorical
P2 treated with beta-blockers
Phase 2: On treatment Beta Blocker at follow up, 0 =; 1 =
Categorical
P2 treated with calcium antagonists
Phase 2: On treatment calcium antagonist at follow up, 0 = ; 1 =
Categorical
treated with diuretics at FUP
Phase 2: Treated with diuretics at follow-up. 0 = ; 1 = ?;
Categorical
treated with lipid lowering drug at FUP
Phase 2: Treated with lipid lowering drug at follow-up. 0 = ; 1 = ;
Categorical
on treatment otherantibp at P3
Phase 3: on treatment other anti bp at phase 3
Categorical
on treatment thiazide at P3
Phase 3: on treatment thiazide at phase 3, 0 = ; 1 = ;
Categorical